Navigation Links
David Luci Joins MacroChem as General Counsel and Vice President Corporate Development
Date:12/6/2007

Luci Brings Successful Track Record of Building Value in Biotech Arena

Through Experience in Business Development and Investment Community

Outreach

WELLESLEY HILLS, Mass., Dec. 6 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTC Bulletin Board: MACM) has appointed David P. Luci, Esq. as General Counsel and Vice President Corporate Development. Mr. Luci will also be Corporate Secretary with responsibilities encompassing all the company's legal matters including compliance with securities regulations and corporate governance. Included in the scope of Corporate Development activities will be responsibility for partnering activities and investor relations.

"I'm very pleased to welcome David to MacroChem. Having recently completed three very important milestones, we are confident that David's extensive experience will help bolster the company's continued momentum," stated Robert DeLuccia, President and CEO of MacroChem. "These key milestones are: last month's announcement of positive interim Phase 2 data for EcoNail(R) for the treatment of onychomycosis; the recent acquisition of exclusive worldwide license rights to pexiganan, a novel topical anti-infective peptide for the treatment of diabetic foot infection, which has already completed two Phase 3 trials; and the recent conversion of all preferred shares into common shares leaving only common stock, warrants, and options outstanding."

Most recently, Mr. Luci served as Executive Vice President and General Counsel of Bioenvision where he established the company's offices in New York, raised over $75 million in capital, and advanced Bioenvision stock listing from OTCBB to AMEX and then to NASDAQ. He was also responsible for garnering analyst interest for a number of investment firms. While at Bioenvision, he in-licensed the company's development-stage lead cancer drug for Japan and Southeast Asia and initiated drug development activities in Japan. He
'/>"/>

SOURCE MacroChem Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
3. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
4. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
5. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
6. St. Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders
7. David Grimes, FHI physician, inducted into Institute of Medicine
8. David Kahal Joins AXA Equitable as National Sales Manager
9. Leading Authority on Health Benefits, David Hom, Joins Board of Directors of Healthcare Technology Innovator, NavigatorMD, Inc.
10. Tree named in honor of Virginia Tech chemist David G.I. Kingston
11. Richard Greco Joins Mediware Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... estimated 29,000 future cancers could be linked to scans performed ... Commonly performed CT scans are exposing patients to far more ... tens of thousands of cancers a year, two new studies ... 14/28 issue of the Archives of Internal Medicine , ... Rita F. Redberg, are calling on clinicians to limit radiation ...
(Date:12/14/2009)... finds, , , MONDAY, Dec. 14 (HealthDay News) -- Here,s ... without a cup or two of java: Coffee and ... 2 diabetes. , That,s the conclusion of an ... drink, the lower your risk of diabetes. Every cup ... in the risk of diabetes, the researchers said. ...
(Date:12/14/2009)... Type 2 diabetes and obesity are linked to an ... suggested that insulin glargine (a synthetic insulin preparation marketed ... a higher risk of certain cancers than other insulins ... were unable to control for important factors such as ... On the other hand, a large randomized trial designed ...
(Date:12/14/2009)... might lead to better treatments for asthma, COPD, researchers ... have identified five genetic variants that influence lung function, ... for lung diseases. , The international team of researchers ... the 2.5 million sites across the human genome in ... the team to the five common genetic variants associated ...
(Date:12/14/2009)... rates for meth and smoking, but concerns about ... News) -- Fewer teenagers are using methamphetamine, but ... of prescription drugs remains high, U.S. health officials ... drugs, such as the hallucinogenic salvia leaf and ... treatment of attention-deficit hyperactivity disorder (ADHD), appear to ...
Breaking Medicine News(10 mins):Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4
... average of 80 die each year while trimming trees , , ... an average of 80 tree-care workers died annually in the ... training programs in this industry. , Almost half of the ... causes of these deaths included being struck by tree branches ...
... genetic manipulation poses, study finds , , THURSDAY, April 23 ... embryonic-like stem cells by using chemical programming instead of ... that has posed the risk of serious health problems ... to make stem cells without genetically altering them could ...
... nodules is high and there are certain ultrasound features, ... not a biopsy is needed, according to a study ... Center, San Francisco, CA. , A total of ... no cancer) were analyzed. "Our study supports previous data ...
... may offer radiologists a fun, alternative method to using a ... to a study performed at the New-York Presbyterian Hospital/Weill Cornell ... offer radiologists relief from repetitive motion injuries as a result ... "We have developed a new fun and exciting way for ...
... with a high degree of confidence, whether or not ... removed through polypectomy, according to a study performed at ... Health in Madison, WI. , The study included ... "In our study, we found that when a clinically ...
... Diffusion weighted MR can accurately identify benign from malignant ... to a study performed at Massachusetts General Hospital in ... that uses an MRI sequence sensitized to the motion ... imaging with CT or MRI uses the size of ...
Other Medicine News:Health News:Scientists Find New Way to Create Stem Cells 2Health News:Popular gaming system may offer radiologists an alternative way to view patient images 2Health News:Non-invasive test accurately identifies gynecologic malignancies 2
(Date:12/14/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced ... the addition of Lt. Gen. Ronald R. Blanck, DO, ... Blanck & Associates, a federal health services consulting firm ... company board now has nine members. ,, Dr. Blanck ... officer and battalion surgeon in Vietnam. He retired 32 ...
(Date:12/14/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... to help maintain the bone health of prostate ... therapy (ADT). Nearly two million men are ... that, while highly effective and considered the "gold ... man,s risk for osteoporosis. ,, As part of ...
(Date:12/14/2009)... DOVER, Del., Dec. 14 Ohr Pharmaceutical Inc. ... selected Allen & Caron Inc, headquartered in Irvine, ... London, as its agency for investor relations and ... stage biotechnology company focused on developing advanced drugs ... pipeline compounds with potentially large, global markets: OHR/AVR118 ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Expands Board of Directors 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 2Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 3SPECT provides high quality images of small tumors 48912 1Pregnant women at high risk of complications from H1N1 influenza 48908 1Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 1Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 2Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 3Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 4
... Israel, February 4 Oramed,Pharmaceuticals, Inc. (OTCBB: ORMP.OB), ... that it has concluded a proof of concept,study ... its,proprietary technology. Eight healthy volunteers came for two ... The insulin suppositories showed rapid insulin absorption ...
... PDUFA Date for Cinryze for Acute HAE Indication is June ... ViroPharma Incorporated (Nasdaq: VPHM ) today announced ... priority review for Cinryze C1 Inhibitor (human) as a treatment ... Biologics License Application (sBLA), submitted to the FDA on December ...
Other Medicine Technology:Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6
Universal, clear, lightweight plastic with smooth edges & ventilation holes for patient comfort...
... exercise BP monitor is designed to automatically ... diastolic BP along with heart rate. It's ... use in treadmill, ergometer and pharmacological stress ... use in research environments., ,Tango excels ...
...
... TraceMasterVue is a cutting-edge ECG ... thin-client functionality and convenient, web-based ... administrative and information technology (IT) ... lower costs, and improved patient ...
Medicine Products: